Strong presence in 10 countries in Northern and Eastern Europe
Net sales of about SEK 3 billion
In December 2010, OneMed was acquired by 3i – an international investor in private equity, infrastructure and debt management, investing in Europe, Asia and North America
POSI TI ONI NG FOR T H E F U T U RE I N H E ALT H C ARE
REDEFINING MEDICAL PROCUREMENT TO RE AP MUTUAL BENEFITS ONE ME D
The healthcare systems of Western, industrialised nations will face significant challenges in the years to come. Ageing populations and declining numbers of healthcare workers increase the costs and threaten the quality of care. In response to this changing customer landscape, OneMed has developed a new proposition to the healthcare systems, introducing performance and cost improvements OneMed has developed as an integrated part of a new proposition to the offering. the healthcare systems,
introducing performance and cost improvements as an integrated part of the offering.
The idea is simple. As a supplier of medical equipment to the healthcare industry, OneMed has full overview of what is prescribed to the individual patient and can follow patient flows. This allows OneMed to forecast or correct prescription mistakes or inefficiencies swiftly. By proactively correcting these situations, OneMed can prevent unnecessary processes and costs to the healthcare system. And the potential is huge: up to 20% of the combined spend pool. The solution, however, is complex. To proactively forecast and correct actions, systems must be well integrated with the healthcare providers’ systems. Further, it requires expertise and co-operation between the healthcare system and OneMed to capture the savings. This is nevertheless the journey OneMed is about OneMed can prevent to embark on – to help unnecessary processes the healthcare system and costs to the succeed while creating a healthcare system. And significant competitive the potential is huge: up advantage. to 20% of the combined
spend pool.
Running the gamut of private equity